Course: Trends in Insulin Prescribing for Patients With Diabetes During the COVID-19 Pandemic in the US
CME Credits: 1.00
Released: 2021-11-03
For the approximately 7 million US individuals with diabetes who rely on insulin, the number of insulin prescriptions rose steadily in the decade before the COVID-19 pandemic. Reduced access to medical care and disruptions in supply related to the pandemic may have decreased access to insulin, with possible adverse consequences for diabetes control. Conversely, emergency Medicaid expansions that increased capacity for telemedicine services during the pandemic may have been associated with improved access to treatment. Therefore, this study aimed to assess whether changes to insulin prescription claims occurred during the COVID-19 pandemic.
Educational Objective
To identify the key insights or developments described in this article
View Full Course